Earnings Results: Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighs
Earnings Results: Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighs
207
views
Gilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations.
Gilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations.

Comments

https://stocktradingwebsites.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!